Barclays analyst Lauren Lieberman raised the firm’s price target on Edgewell Personal Care (EPC) to $21 from $19 and keeps an Equal Weight rating on the shares. The firm says that when removing the “noise” from the feminine care divestiture and earlier U.S. sun care orders, Edgewell’s fiscal Q1 results were largely in-line with expectations and the outlook for the remainder of the year is fully intact.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care Affirms No Material Changes to 2025 Risk Profile Disclosures
- Edgewell Personal Care Bets on Back-Half Turnaround
- Edgewell Reaffirms Outlook After Feminine Care Divestiture
- Edgewell Personal Care sees FY26 adjusted EPS $1.70-$2.10, consensus $2.34
- Edgewell Personal Care reports Q1 adjusted EPS from cont. ops. (16c)
